Health

Coronavirus drug shows promise at Carolina

Potential relief to the coronavirus pandemic.

Potential relief to the coronavirus pandemic.

UNC Gillings School of Global Public Health researchers are testing a new broad-spectrum antiviral drug that could potentially be a relief to the global coronavirus pandemic.

Ralph Baric, an epidemiologist in the Gillings School of Global Public Health, heads a lab testing a broad-spectrum antiviral drug called remdesivir.

Six years ago, the lab partnered with the biopharmaceutical company Gilead Sciences Inc. Their goal was testing the company’s antiviral drugs to curb emerging viral diseases often overlooked by big pharmaceutical companies, said Tim Sheahan, a virologist in Baric’s lab.

Coronaviruses were of particular interest. Fast forward to today, and the intravenous drug remdesivir could potentially be a relief to this global pandemic. Just like broad-spectrum antibiotics — which can cure a wide range of bacterial infections — a broad-spectrum antiviral like remdesivir can work against genetically distinct viruses.

Read the complete Carolina Story…Opens in new window

At the UNC Gillings School, we’re on the front lines of public health. From disease prevention to promoting equity and engineering a healthier planet: We’re on it. Every two weeks, we share top stories of local and global impact in our Front Lines newsletter. Sign up nowOpens in new window.

Carolina on the Frontlines

UNC-Chapel Hill is on the frontlines of the COVID-19 pandemic. View the ways you can immediately support Carolina researchers, caregivers and students who drive change, accelerate impact and provide a future for us all.

Support Carolina on the Frontlines

UNC Gillings School of Global Public Health Funding Priorities

Readers Also Viewed...

Health

The Importance of Face Masks

Limiting the transmission of COVID-19

Community

Emergency Preparedness, Ethics and Equity Speaker Series

Fostering inclusive excellence during turbulent times

Ralph Baric
Research

Remdesivir proves effective

“Game-Changer” treatment for patients with COVID-19

Health

Monitoring asymptomatic COVID-19 cases

Partnering with state and local agencies to assess COVID-19 prevalence

Ralph Baric
Research

In Search of the Most Effective COVID-19 Therapeutics

Ralph Baric and his team are testing hundreds of existing compounds against COVID-19 for researchers and labs across the world, in search of the most effective therapeutics.

Rachel Noble
Research

Testing Water Systems for COVID-19

UNC-Chapel Hill researcher Rachel Noble is studying the transmissibility of COVID-19 through water and the environment.